Breaking for Thanksgiving on a High Note

Another Solid Options Effort:

We took a bold stance in yesterday morning’s premarket report, going bearish on all three sets of options ideas we formulated for the session. While all three target stocks turned in green candles on the day, the first couple hours of the session definitely played into our hands nicely. There were substantial opportunities for gains on the table for all three of our interests.

We were targeting the URBN Weekly $35-33 Puts, the DLTR Weekly $132-130 Puts, and the BBY Weekly $122-119 Puts. The following are the morning ranges and total possible profits that could have been attained off of these ideas:

URBN Weekly $35-33 Puts
$35:
 1.70-3.20 (+88%)
$34: .90-2.30 (+156%)
$33: .55-1.55 (+181%)
_____

DLTR Weekly $132-130 Puts
$132: .26-.77 (+196%)
$131: .20-.45 (+125%)
$130: .17-.44 (+159%)
_____

BBY Weekly $122-119 Puts

$122: 4.25-7.25 (+70%)
$121: 3.00-5.60 (+87%)
$120: 3.00-5.73 (+92%)
$119: 2.62-4.99 (+90%)


Fresh Options Ideas:
DE Weekly $352.50-360
FUTU Weekly $54-57 Calls
HPQ Weekly $33-35 Calls


iSpecimen, Inc. ISPC – Recap:

On Monday morning, we tagged ISPC in our watchlist, and that stock went on to make a nice intraweek move.

From a low of 8.06, the stock ran as high as 18.50. That works out to an increase of 130% which is an excellent short term move for a NASDAQ stock in this price range. In those two sessions. ISPC has traded roughly ten times its 30-day average volume.


Extended Watchlist: 
OCUP, BFRI, GAME, IINN, LGVN, BIOL, SOPA, PTN, SNPW, PUGE, TGGI, JPEX, IVDA, SMCE

Going Bearish on Earnings Reporters

Options Review:

We’ve been back on our Midas Touch options trading business over the last several sessions, and yesterday morning was no different. We were just patting ourselves on the back for 100% accuracy on the previous session’s bangers, and we managed to do it again to start this holiday-shortened week.

We signaled ranges on a couple of plays, highlighting the SPY 11/22 $469-470 Calls, as well as going short on the CRNC 12/17 $105-95 Puts. Both turned out to be excellent notions, and the board was fully green for yet another day. The end of this week will be rather subdued, with a day off for Thanksgiving and just a half trading day for Black Friday, so it’s good we’re getting these in now.

Here are the total possible profits that could have been banked off of yesterday’s targets:

SPY 11/22 $469-470 Calls
$469:
 1.99-4.50 (+126%)
$470: .62-2.40 (+287%)
_____

CRNC 12/17 $105-95 Puts 
$105: 15.00-22.46 (+50%)
$100: 9.70-18.20 (+88%)
$95: 6.00-13.49 (+125%)


Fresh Options Ideas: 
URBN Weekly $35-33 Puts
DLTR Weekly $132-130 Puts
BBY Weekly $122-119 Puts


Extended Watchlist: 
ISPC, KTTA, PTPI, APVO, QLGN, AADI, TNXP, OSCI, VIZC, PUGE, TIPS, LVGI

More Multi-bag Options Runners

CURE Pharmaceutical Holding Corp. CURR

We find CURR very interesting because of the company’s unique systems/methods for delivering drugs into the human body. It’s not often that we run into an OTC traded play with intriguing proprietary technologies.

The Company’s efforts to further position itself as an integrated healthcare company with its recent acquisition of The Sera Labs, a high-margin, multi-channel marketing and branding company with accelerating sales of its more than 20 products in the health & wellness, beauty, and pets categories and strong traction in both e-commerce and wholesale-to-retail distribution with total retail doors exceeding 8,850 in the U.S. to date. CURE acquired 100 percent of privately held The Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition.

The Sera Labs newest consumer product that uses CURE’s patented and advanced oral thin film strip technology under the trademark name Nutri-Strips with RAD3 (Rapid Activation Delivery) to deliver novel vitamins and supplements to consumers across the nation.

The Company’s future plans and focus on research and development into CURE’s pharmaceutical programs and The Sera Labs commitment to innovating its offerings with a “tele-wellness” program and exciting new products.

In addition to an interesting backstory the CURR chart itself looks rather attractive at the moment. The stock has just bounced off of its 52-week low, with a recent increase in volume. The PPS over the last two sessions has held a higher low, so we’ll be looking for the further establishment of higher highs and higher lows off of its bottom. Key resistance points to note are the 50DMA at 1.22 and the 200DMA at 1.73. We are definitely going to put this play on our watchlist this today and continue to track its progress going forward.


Options Recaps

We had a clean sweep on options in yesterday’s report, with each of the three sets of ideas we offered up to our readers performed quite well on the day. Here are the ranges and total potential intraday gains that were on the table:

DLTR Weekly $104-106 Calls
$104
: 2.38-8.11 (+241%)
$105: 1.94-6.94 (+258%)
$106: 1.03-6.45 (+526%)
_____

AMBA Weekly $68.50-70 Calls
$68.50
: 3.28-6.50 (+98%)
$69: 2.20-7.20 (+227%)
$70: 1.55-6.39 (+312%)
_____

NTNX Weekly $30-32 Calls 
$30: .50-1.11 (+222%)
$31: .24-.60 (+250%)
$32: .05-.30 (+500%)


Fresh Options Ideas: 
JWN Weekly $24-26 Calls*
DE Weekly $265-270 Calls*
GAP Weekly $24.50-23.50 Puts*

*Please note that these weekly contracts will expire early on Friday at the 1PM close, following tomorrow’s holiday. We hope everyone has a safe and happy Thanksgiving!


Extended Watchlist:
ENZC, TSNP, HYSR, MGTI